|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 200 out of 1389 for Smad3

0.031s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Publication
First Author: Hachimine D
Year: 2008
Journal: Int J Oncol
Title: Involvement of Smad3 phosphoisoform-mediated signaling in the development of colonic cancer in IL-10-deficient mice.
Volume: 32
Issue: 6
Pages: 1221-6
Publication
First Author: Jeong DH
Year: 2013
Journal: Int J Mol Sci
Title: Smad3 deficiency ameliorates hepatic fibrogenesis through the expression of senescence marker protein-30, an antioxidant-related protein.
Volume: 14
Issue: 12
Pages: 23700-10
Publication  
First Author: Xia M
Year: 2017
Journal: Nat Commun
Title: Ash1l and lnc-Smad3 coordinate Smad3 locus accessibility to modulate iTreg polarization and T cell autoimmunity.
Volume: 8
Pages: 15818
Publication
First Author: Tannehill-Gregg SH
Year: 2004
Journal: Vet Pathol
Title: The roles of Smad2 and Smad3 in the development of chemically induced skin tumors in mice.
Volume: 41
Issue: 3
Pages: 278-82
Publication
First Author: Yang YA
Year: 2006
Journal: Cancer Cell
Title: Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2.
Volume: 9
Issue: 6
Pages: 445-57
Publication  
First Author: McDowell CM
Year: 2013
Journal: Exp Eye Res
Title: Smad3 is necessary for transforming growth factor-beta2 induced ocular hypertension in mice.
Volume: 116
Pages: 419-23
Publication
First Author: Latella G
Year: 2009
Journal: Liver Int
Title: Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice.
Volume: 29
Issue: 7
Pages: 997-1009
Publication
First Author: Latella G
Year: 2009
Journal: Eur J Clin Invest
Title: Smad3 loss confers resistance to the development of trinitrobenzene sulfonic acid-induced colorectal fibrosis.
Volume: 39
Issue: 2
Pages: 145-56
Publication
First Author: Domino SE
Year: 2007
Journal: Tumour Biol
Title: Cell surface fucosylation does not affect development of colon tumors in mice with germline Smad3 mutation.
Volume: 28
Issue: 2
Pages: 77-83
Publication
First Author: Wang W
Year: 2016
Journal: PLoS Genet
Title: Smad2 and Smad3 Regulate Chondrocyte Proliferation and Differentiation in the Growth Plate.
Volume: 12
Issue: 10
Pages: e1006352
Publication
First Author: Labbé E
Year: 1998
Journal: Mol Cell
Title: Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2.
Volume: 2
Issue: 1
Pages: 109-20
Publication  
First Author: Xu Z
Year: 2017
Journal: Nat Commun
Title: SMURF2 regulates bone homeostasis by disrupting SMAD3 interaction with vitamin D receptor in osteoblasts.
Volume: 8
Pages: 14570
Publication  
First Author: He H
Year: 2023
Journal: Int J Mol Sci
Title: Smad3 Mediates Diabetic Dyslipidemia and Fatty Liver in db/db Mice by Targeting PPARδ.
Volume: 24
Issue: 14
Publication
First Author: Mori H
Year: 2015
Journal: Am J Pathol
Title: Smad3 deficiency leads to mandibular condyle degradation via the sphingosine 1-phosphate (S1P)/S1P3 signaling axis.
Volume: 185
Issue: 10
Pages: 2742-56
Publication
First Author: Alvarez J
Year: 2004
Journal: Dev Dyn
Title: Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
Volume: 230
Issue: 4
Pages: 685-99
Publication
First Author: Duan WJ
Year: 2014
Journal: Am J Pathol
Title: Opposing roles for Smad2 and Smad3 in peritoneal fibrosis in vivo and in vitro.
Volume: 184
Issue: 8
Pages: 2275-84
Publication
First Author: Trotta R
Year: 2008
Journal: J Immunol
Title: TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells.
Volume: 181
Issue: 6
Pages: 3784-92
Publication
First Author: Li J
Year: 2010
Journal: Diabetes
Title: Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy.
Volume: 59
Issue: 10
Pages: 2612-24
Publication
First Author: Zhong X
Year: 2020
Journal: Cell Mol Gastroenterol Hepatol
Title: SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate Cells.
Volume: 10
Issue: 2
Pages: 341-364
Publication
First Author: Ding H
Year: 2020
Journal: J Cell Mol Med
Title: Smad3 gene C-terminal phosphorylation site mutation aggravates CCl4 -induced inflammation in mice.
Volume: 24
Issue: 12
Pages: 7044-7054
Publication
First Author: Kim SY
Year: 2011
Journal: Mol Cell Endocrinol
Title: A truncated, activin-induced Smad3 isoform acts as a transcriptional repressor of FSHβ expression in mouse pituitary.
Volume: 342
Issue: 1-2
Pages: 64-72
Publication
First Author: Howell M
Year: 2001
Journal: Mech Dev
Title: Xenopus Smad3 is specifically expressed in the chordoneural hinge, notochord and in the endocardium of the developing heart.
Volume: 104
Issue: 1-2
Pages: 147-50
Publication
First Author: Li Q
Year: 2008
Journal: Mol Cell Biol
Title: Redundant roles of SMAD2 and SMAD3 in ovarian granulosa cells in vivo.
Volume: 28
Issue: 23
Pages: 7001-11
Publication
First Author: Sriram S
Year: 2014
Journal: Mol Endocrinol
Title: Myostatin augments muscle-specific ring finger protein-1 expression through an NF-kB independent mechanism in SMAD3 null muscle.
Volume: 28
Issue: 3
Pages: 317-30
Publication
First Author: Goodman CA
Year: 2013
Journal: Mol Endocrinol
Title: Smad3 induces atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo.
Volume: 27
Issue: 11
Pages: 1946-57
Publication
First Author: Sun JG
Year: 2016
Journal: Oncotarget
Title: Yap1 promotes the survival and self-renewal of breast tumor initiating cells via inhibiting Smad3 signaling.
Volume: 7
Issue: 9
Pages: 9692-706
Publication
First Author: Kremer M
Year: 2014
Journal: Transpl Int
Title: Smad3 signaling in the regenerating liver: implications for the regulation of IL-6 expression.
Volume: 27
Issue: 7
Pages: 748-58
Publication
First Author: Ono H
Year: 2018
Journal: Sci Rep
Title: Novel Interplay Between Smad1 and Smad3 Phosphorylation via AGE Regulates the Progression of Diabetic Nephropathy.
Volume: 8
Issue: 1
Pages: 10548
Publication
First Author: Sheng J
Year: 2021
Journal: Theranostics
Title: Smad3 deficiency promotes beta cell proliferation and function in db/db mice via restoring Pax6 expression.
Volume: 11
Issue: 6
Pages: 2845-2859
Publication
First Author: Kumari R
Year: 2021
Journal: FASEB J
Title: SMAD2 and SMAD3 differentially regulate adiposity and the growth of subcutaneous white adipose tissue.
Volume: 35
Issue: 12
Pages: e22018
Publication
First Author: Dong Y
Year: 2013
Journal: Am J Physiol Endocrinol Metab
Title: Interactions between p-Akt and Smad3 in injured muscles initiate myogenesis or fibrogenesis.
Volume: 305
Issue: 3
Pages: E367-75
Publication
First Author: Tsurutani Y
Year: 2011
Journal: Biochem Biophys Res Commun
Title: The roles of transforming growth factor-β and Smad3 signaling in adipocyte differentiation and obesity.
Volume: 407
Issue: 1
Pages: 68-73
Publication
First Author: Suh JH
Year: 2006
Journal: J Biol Chem
Title: Orphan nuclear receptor small heterodimer partner inhibits transforming growth factor-beta signaling by repressing SMAD3 transactivation.
Volume: 281
Issue: 51
Pages: 39169-78
Publication
First Author: Dunn NR
Year: 2004
Journal: Development
Title: Combinatorial activities of Smad2 and Smad3 regulate mesoderm formation and patterning in the mouse embryo.
Volume: 131
Issue: 8
Pages: 1717-28
Publication
First Author: Wang Y
Year: 2007
Journal: Exp Neurol
Title: Smad3 null mice display more rapid wound closure and reduced scar formation after a stab wound to the cerebral cortex.
Volume: 203
Issue: 1
Pages: 168-84
Publication
First Author: McKarns SC
Year: 2004
Journal: J Immunol
Title: Smad3 is essential for TGF-beta 1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation.
Volume: 172
Issue: 7
Pages: 4275-84
Publication
First Author: Winbanks CE
Year: 2012
Journal: J Cell Biol
Title: Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin.
Volume: 197
Issue: 7
Pages: 997-1008
Publication  
First Author: Tapia-González S
Year: 2013
Journal: Cell Commun Signal
Title: Smad3 is required for the survival of proliferative intermediate progenitor cells in the dentate gyrus of adult mice.
Volume: 11
Pages: 93
Publication
First Author: Zhao J
Year: 1998
Journal: Dev Biol
Title: Abrogation of Smad3 and Smad2 or of Smad4 gene expression positively regulates murine embryonic lung branching morphogenesis in culture.
Volume: 194
Issue: 2
Pages: 182-95
Publication
First Author: Kim EY
Year: 2011
Journal: FEBS Lett
Title: Lipopolysaccharide inhibits transforming growth factor-beta1-stimulated Smad6 expression by inducing phosphorylation of the linker region of Smad3 through a TLR4-IRAK1-ERK1/2 pathway.
Volume: 585
Issue: 5
Pages: 779-85
Publication
First Author: Philipp-Staheli J
Year: 2002
Journal: Cancer Cell
Title: Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice.
Volume: 1
Issue: 4
Pages: 355-68
Publication
First Author: Looyenga BD
Year: 2007
Journal: Mol Endocrinol
Title: Genetic removal of Smad3 from inhibin-null mice attenuates tumor progression by uncoupling extracellular mitogenic signals from the cell cycle machinery.
Volume: 21
Issue: 10
Pages: 2440-57
Publication  
First Author: Li LF
Year: 2015
Journal: Respir Res
Title: Activation of Src-dependent Smad3 signaling mediates the neutrophilic inflammation and oxidative stress in hyperoxia-augmented ventilator-induced lung injury.
Volume: 16
Pages: 112
Publication
First Author: Flanders KC
Year: 2003
Journal: Am J Pathol
Title: Interference with transforming growth factor-beta/ Smad3 signaling results in accelerated healing of wounds in previously irradiated skin.
Volume: 163
Issue: 6
Pages: 2247-57
Publication
First Author: Islam R
Year: 2018
Journal: J Cell Physiol
Title: Peptidyl-prolyl cis-trans isomerase NIMA interacting 1 regulates skeletal muscle fusion through structural modification of Smad3 in the linker region.
Volume: 233
Issue: 12
Pages: 9390-9403
Publication
First Author: Park BV
Year: 2016
Journal: Cancer Discov
Title: TGFβ1-Mediated SMAD3 Enhances PD-1 Expression on Antigen-Specific T Cells in Cancer.
Volume: 6
Issue: 12
Pages: 1366-1381
Publication
First Author: Sugiyama Y
Year: 2012
Journal: Int Immunol
Title: Smad2 and Smad3 are redundantly essential for the suppression of iNOS synthesis in macrophages by regulating IRF3 and STAT1 pathways.
Volume: 24
Issue: 4
Pages: 253-65
Publication  
First Author: Chen B
Year: 2022
Journal: J Mol Cell Cardiol
Title: Differential effects of Smad2 and Smad3 in regulation of macrophage phenotype and function in the infarcted myocardium.
Volume: 171
Pages: 1-15
Publication
First Author: Fortin J
Year: 2014
Journal: FASEB J
Title: Follicle-stimulating hormone synthesis and fertility are intact in mice lacking SMAD3 DNA binding activity and SMAD2 in gonadotrope cells.
Volume: 28
Issue: 3
Pages: 1474-85
Publication
First Author: Sun YB
Year: 2013
Journal: PLoS One
Title: Endothelial dysfunction exacerbates renal interstitial fibrosis through enhancing fibroblast Smad3 linker phosphorylation in the mouse obstructed kidney.
Volume: 8
Issue: 12
Pages: e84063
Publication
First Author: Sakurai A
Year: 2019
Journal: PLoS One
Title: Involvement of Elf3 on Smad3 activation-dependent injuries in podocytes and excretion of urinary exosome in diabetic nephropathy.
Volume: 14
Issue: 5
Pages: e0216788
Publication
First Author: Kocic J
Year: 2012
Journal: Eur J Cancer
Title: SMAD3 is essential for transforming growth factor-β1-induced urokinase type plasminogen activator expression and migration in transformed keratinocytes.
Volume: 48
Issue: 10
Pages: 1550-7
Publication  
First Author: Umezu T
Year: 2021
Journal: Biochem Biophys Res Commun
Title: Smad2 and Smad3 expressed in skeletal muscle promote immobilization-induced bone atrophy in mice.
Volume: 582
Pages: 111-117
Publication
First Author: Falanga V
Year: 2004
Journal: Wound Repair Regen
Title: Full-thickness wounding of the mouse tail as a model for delayed wound healing: accelerated wound closure in Smad3 knock-out mice.
Volume: 12
Issue: 3
Pages: 320-6
GXD Expression
Probe: MGI:6431055
Assay Type: Immunohistochemistry
Annotation Date: 2022-06-02
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3274322
Pattern: Not Specified
Stage: TS22
Assay Id: MGI:7281830
Age: embryonic day 14.5
Image: 4C
Note: Sample was from cerebral cortex. Phosphorylated Smad3 expression level was reduced in the mutant.
Specimen Label: 4C
Detected: true
Specimen Num: 3
GXD Expression
Probe: MGI:6431055
Assay Type: Immunohistochemistry
Annotation Date: 2022-06-02
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3274322
Pattern: Not Specified
Stage: TS22
Assay Id: MGI:7281830
Age: embryonic day 14.5
Image: 4D
Note: Sample was from midbrain. Phosphorylated Smad3 expression level was reduced in the mutant.
Specimen Label: 4D
Detected: true
Specimen Num: 4
GXD Expression
Probe: MGI:6431055
Assay Type: Immunohistochemistry
Annotation Date: 2022-06-02
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3274322
Pattern: Not Specified
Stage: TS22
Assay Id: MGI:7281830
Age: embryonic day 14.5
Image: 4J
Note: Sample was from cerebral cortex. Phosphorylated Smad3 expression level was reduced in the mutant.
Specimen Label: 4J
Detected: true
Specimen Num: 7
GXD Expression
Probe: MGI:6431055
Assay Type: Immunohistochemistry
Annotation Date: 2022-06-02
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3274322
Pattern: Not Specified
Stage: TS22
Assay Id: MGI:7281830
Age: embryonic day 14.5
Image: 4K
Note: Sample was from midbrain. Phosphorylated Smad3 expression level was reduced in the mutant.
Specimen Label: 4K
Detected: true
Specimen Num: 8
Publication
First Author: Wu Q
Year: 2008
Journal: Arthritis Rheum
Title: Induction of an osteoarthritis-like phenotype and degradation of phosphorylated Smad3 by Smurf2 in transgenic mice.
Volume: 58
Issue: 10
Pages: 3132-44
Publication
First Author: Hama T
Year: 2017
Journal: Am J Physiol Renal Physiol
Title: Aberrant Smad3 phosphoisoforms in cyst-lining epithelial cells in the cpk mouse, a model of autosomal recessive polycystic kidney disease.
Volume: 313
Issue: 6
Pages: F1223-F1231
Publication
First Author: Huang S
Year: 2020
Journal: Biochim Biophys Acta Mol Cell Res
Title: The role of Smad2 and Smad3 in regulating homeostatic functions of fibroblasts in vitro and in adult mice.
Volume: 1867
Issue: 7
Pages: 118703
Publication
First Author: Borton AJ
Year: 2001
Journal: J Bone Miner Res
Title: The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis.
Volume: 16
Issue: 10
Pages: 1754-64
Publication
First Author: Yang YA
Year: 2002
Journal: Cell Growth Differ
Title: Smad3 in the mammary epithelium has a nonredundant role in the induction of apoptosis, but not in the regulation of proliferation or differentiation by transforming growth factor-beta.
Volume: 13
Issue: 3
Pages: 123-30
Publication
First Author: Kohn EA
Year: 2012
Journal: Mol Cancer Res
Title: Biological responses to TGF-β in the mammary epithelium show a complex dependency on Smad3 gene dosage with important implications for tumor progression.
Volume: 10
Issue: 10
Pages: 1389-99
Publication
First Author: Sato F
Year: 2019
Journal: Am J Pathol
Title: Smad3 Suppresses Epithelial Cell Migration and Proliferation via the Clock Gene Dec1, Which Negatively Regulates the Expression of Clock Genes Dec2 and Per1.
Volume: 189
Issue: 4
Pages: 773-783
Publication
First Author: Li L
Year: 2006
Journal: Nat Immunol
Title: A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance.
Volume: 7
Issue: 11
Pages: 1157-65
Publication
First Author: Xu L
Year: 2010
Journal: Immunity
Title: Positive and negative transcriptional regulation of the Foxp3 gene is mediated by access and binding of the Smad3 protein to enhancer I.
Volume: 33
Issue: 3
Pages: 313-25
Publication
First Author: Schlenner SM
Year: 2012
Journal: J Exp Med
Title: Smad3 binding to the foxp3 enhancer is dispensable for the development of regulatory T cells with the exception of the gut.
Volume: 209
Issue: 9
Pages: 1529-35
Publication
First Author: Mishra B
Year: 2004
Journal: Liver Int
Title: Loss of cooperative function of transforming growth factor-beta signaling proteins, smad3 with embryonic liver fodrin, a beta-spectrin, in primary biliary cirrhosis.
Volume: 24
Issue: 6
Pages: 637-45
Protein
Organism: Mus musculus/domesticus
Length: 209  
Fragment?: true
Publication
First Author: Kriseman M
Year: 2019
Journal: Proc Natl Acad Sci U S A
Title: Uterine double-conditional inactivation of Smad2 and Smad3 in mice causes endometrial dysregulation, infertility, and uterine cancer.
Volume: 116
Issue: 9
Pages: 3873-3882
Publication
First Author: Dunn NR
Year: 2005
Journal: Genes Dev
Title: Mice exclusively expressing the short isoform of Smad2 develop normally and are viable and fertile.
Volume: 19
Issue: 1
Pages: 152-63
Publication
First Author: Nold MF
Year: 2010
Journal: Nat Immunol
Title: IL-37 is a fundamental inhibitor of innate immunity.
Volume: 11
Issue: 11
Pages: 1014-22
Publication
First Author: Han Y
Year: 2018
Journal: Cell
Title: Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression.
Volume: 173
Issue: 3
Pages: 634-648.e12
Publication
First Author: Kano K
Year: 1999
Journal: J Vet Med Sci
Title: Cloning and studies of the mouse cDNA encoding Smad3.
Volume: 61
Issue: 3
Pages: 213-9
Publication
First Author: Nam KT
Year: 2012
Journal: Lab Invest
Title: Gastric tumor development in Smad3-deficient mice initiates from forestomach/glandular transition zone along the lesser curvature.
Volume: 92
Issue: 6
Pages: 883-95
Publication
First Author: Wang W
Year: 2022
Journal: Adv Sci (Weinh)
Title: SARS-CoV-2 N Protein Induces Acute Kidney Injury via Smad3-Dependent G1 Cell Cycle Arrest Mechanism.
Volume: 9
Issue: 3
Pages: e2103248
Publication
First Author: Hosokawa R
Year: 2005
Journal: J Invest Dermatol
Title: Functional significance of Smad2 in regulating basal keratinocyte migration during wound healing.
Volume: 125
Issue: 6
Pages: 1302-9
Publication
First Author: Huang X
Year: 2018
Journal: Arterioscler Thromb Vasc Biol
Title: MicroRNA-21 Knockout Exacerbates Angiotensin II-Induced Thoracic Aortic Aneurysm and Dissection in Mice With Abnormal Transforming Growth Factor-β-SMAD3 Signaling.
Volume: 38
Issue: 5
Pages: 1086-1101
Publication  
First Author: Shirai K
Year: 2006
Journal: Mol Vis
Title: A new model of anterior subcapsular cataract: involvement of TGFbeta/Smad signaling.
Volume: 12
Pages: 681-91
Publication
First Author: Lin HM
Year: 2009
Journal: J Biol Chem
Title: Transforming growth factor-beta/Smad3 signaling regulates insulin gene transcription and pancreatic islet beta-cell function.
Volume: 284
Issue: 18
Pages: 12246-57
Publication
First Author: Ramirez AM
Year: 2006
Journal: Am J Transplant
Title: Myofibroblast transdifferentiation in obliterative bronchiolitis: tgf-beta signaling through smad3-dependent and -independent pathways.
Volume: 6
Issue: 9
Pages: 2080-8
Publication
First Author: Vetuschi A
Year: 2006
Journal: Eur J Clin Invest
Title: Smad3-null mice lack interstitial cells of Cajal in the colonic wall.
Volume: 36
Issue: 1
Pages: 41-8
Publication
First Author: Ghayur A
Year: 2019
Journal: Am J Physiol Renal Physiol
Title: SMAD3-dependent and -independent pathways in glomerular injury associated with experimental glomerulonephritis.
Volume: 317
Issue: 1
Pages: F152-F162
Publication
First Author: Li JH
Year: 2009
Journal: Mol Immunol
Title: Suppressed acute phase response to LPS-induced hepatic injury in Smad3-deficient mice.
Volume: 46
Issue: 3
Pages: 362-5
Publication
First Author: Matsuura I
Year: 2004
Journal: Nature
Title: Cyclin-dependent kinases regulate the antiproliferative function of Smads.
Volume: 430
Issue: 6996
Pages: 226-31
Publication
First Author: Wang A
Year: 2007
Journal: Am J Physiol Renal Physiol
Title: Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.
Volume: 293
Issue: 5
Pages: F1657-65
Publication
First Author: Radeke HH
Year: 2005
Journal: J Immunol
Title: Overlapping signaling pathways of sphingosine 1-phosphate and TGF-beta in the murine Langerhans cell line XS52.
Volume: 174
Issue: 5
Pages: 2778-86
Publication
First Author: Li G
Year: 2006
Journal: Mol Endocrinol
Title: Role of steroid receptor coactivators in glucocorticoid and transforming growth factor beta regulation of plasminogen activator inhibitor gene expression.
Volume: 20
Issue: 5
Pages: 1025-34
Publication  
First Author: Zhou Q
Year: 2015
Journal: Sci Rep
Title: Identification of Genes Associated with Smad3-dependent Renal Injury by RNA-seq-based Transcriptome Analysis.
Volume: 5
Pages: 17901
Publication
First Author: Esguerra CV
Year: 2007
Journal: Development
Title: Ttrap is an essential modulator of Smad3-dependent Nodal signaling during zebrafish gastrulation and left-right axis determination.
Volume: 134
Issue: 24
Pages: 4381-93
Publication
First Author: Tan NS
Year: 2005
Journal: J Biol Chem
Title: Genetic- or transforming growth factor-beta 1-induced changes in epidermal peroxisome proliferator-activated receptor beta/delta expression dictate wound repair kinetics.
Volume: 280
Issue: 18
Pages: 18163-70
Publication
First Author: Yadav H
Year: 2011
Journal: Cell Metab
Title: Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling.
Volume: 14
Issue: 1
Pages: 67-79
Publication
First Author: Hjelmeland AB
Year: 2005
Journal: Mol Cell Biol
Title: Loss of Smad3-mediated negative regulation of Runx2 activity leads to an alteration in cell fate determination.
Volume: 25
Issue: 21
Pages: 9460-8
Publication
First Author: Ring C
Year: 2002
Journal: Genes Dev
Title: The role of a Williams-Beuren syndrome-associated helix-loop-helix domain-containing transcription factor in activin/nodal signaling.
Volume: 16
Issue: 7
Pages: 820-35
Publication
First Author: Lee HJ
Year: 2013
Journal: Biochem Biophys Res Commun
Title: Angiopoietin-like protein 2, a chronic inflammatory mediator, is a new target induced by TGF-β1 through a Smad3-dependent mechanism.
Volume: 430
Issue: 3
Pages: 981-6
Publication
First Author: Hong HY
Year: 2013
Journal: Biochem Biophys Res Commun
Title: 14-3-3 σ is a new target up-regulated by transforming growth factor-β1 through a Smad3-dependent mechanism.
Volume: 432
Issue: 1
Pages: 193-7
Publication  
First Author: Du Y
Year: 2021
Journal: Int J Mol Sci
Title: Heightened Crescentic Glomerulonephritis in Immune Challenged 129sv Mice Is TGF-β/Smad3 Dependent.
Volume: 22
Issue: 4
Publication
First Author: Maggio-Price L
Year: 2006
Journal: Cancer Res
Title: Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice.
Volume: 66
Issue: 2
Pages: 828-38
Publication
First Author: Epperly MW
Year: 2005
Journal: Exp Hematol
Title: Increased longevity of hematopoiesis in continuous bone marrow cultures and adipocytogenesis in marrow stromal cells derived from Smad3(-/-) mice.
Volume: 33
Issue: 3
Pages: 353-62